CA3275155A1 - Inhibiteur de hdac et son utilisation - Google Patents

Inhibiteur de hdac et son utilisation

Info

Publication number
CA3275155A1
CA3275155A1 CA3275155A CA3275155A CA3275155A1 CA 3275155 A1 CA3275155 A1 CA 3275155A1 CA 3275155 A CA3275155 A CA 3275155A CA 3275155 A CA3275155 A CA 3275155A CA 3275155 A1 CA3275155 A1 CA 3275155A1
Authority
CA
Canada
Prior art keywords
hdac inhibitor
hdac
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3275155A
Other languages
English (en)
Inventor
Ruihua XU
Feng Wang
Yuli XIE
Wenzhong Liu
Lihui QIAN
Original Assignee
Wigen Biomedicine Technology Shanghai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wigen Biomedicine Technology Shanghai Co Ltd filed Critical Wigen Biomedicine Technology Shanghai Co Ltd
Publication of CA3275155A1 publication Critical patent/CA3275155A1/fr
Pending legal-status Critical Current

Links

CA3275155A 2022-12-07 2023-12-06 Inhibiteur de hdac et son utilisation Pending CA3275155A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202211570665.7 2022-12-07
CN202310697924.0 2023-06-13

Publications (1)

Publication Number Publication Date
CA3275155A1 true CA3275155A1 (fr) 2025-10-30

Family

ID=

Similar Documents

Publication Publication Date Title
EP4389738A4 (fr) Inhibiteur de sos1 et son utilisation
EP4186894A4 (fr) Composé inhibiteur de fgfr et son utilisation
EP4378938A4 (fr) Nouvel inhibiteur de parp7 et son utilisation
EP4142717A4 (fr) Inhibiteurs d'irak et leurs utilisations
EP4338737A4 (fr) Inhibiteur de parp7 et son utilisation
CA3262084A1 (fr) Inhibiteurs d'histone désacétylase et leur utilisation
AU2023414945A1 (en) Alpha-v-beta-8 integrin inhibitors and uses thereof
EP4330228A4 (fr) Inhibiteurs de g-alpha-s et leurs utilisations
EP4393921A4 (fr) Composé de nalidinone en tant qu'inhibiteur de fgfr4 et utilisation associée
EP4277884A4 (fr) Composés de salicylamide substitués et leur utilisation
HK40102613A (en) Novel parp7 inhibitor and use thereof
EP4431496A4 (fr) Inhibiteur de la ferroptose et son utilisation
HK40117301A (en) Peptide inhibitor and use thereof
HK40111156A (en) Novel hdac inhibitors and therapeutic use thereof
CA3280755A1 (fr) Méthodes et compositions faisant intervenir un inhibiteur de l'hdac cardio-toléré
CA3277802A1 (fr) Inhibiteur d'intégrase et son utilisation
CA3299252A1 (fr) Inhibiteurs de trim7 et leurs utilisations
CA3299235A1 (fr) Inhibiteurs de trim7 et leurs utilisations
HK40118085A (en) Pde4b inhibitor and use thereof
CA3264104A1 (fr) Inhibiteur de pde4b et son utilisation
HK40114986A (en) Pde4b inhibitor and use thereof
HK40112336A (en) Lpxc inhibitors and uses thereof
HK40130351A (en) Pi3kα inhibitor and use thereof
CA3296317A1 (fr) Inhibiteur de tradd et son utilisation
CA3292331A1 (en) New micropeptide hmbj and use thereof